163 related articles for article (PubMed ID: 24672130)
1. Effects of zafirlukast on the function of humanpolymorphonuclear neutrophil leukocytes in asthmatic patients: A prospective, controlled, in vitro study.
Al-Zamil HA; Ai-Twaijiri AS; Al-Mobeireek AF; Mustafa AA
Curr Ther Res Clin Exp; 2005 Jul; 66(4):279-93. PubMed ID: 24672130
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of zafirlukast on respiratory bursts of human neutrophils.
Braga PC; Dal Sasso M; Dal Negro R
Drugs Exp Clin Res; 2002; 28(4):133-45. PubMed ID: 12512231
[TBL] [Abstract][Full Text] [Related]
3. Effects of Montelukast on free radical production in whole blood and isolated human polymorphonuclear neutrophils (PMNs) in asthmatic children.
Al Saadi MM; Meo SA; Mustafa A; Shafi A; Tuwajri AS
Saudi Pharm J; 2011 Oct; 19(4):215-20. PubMed ID: 23960762
[TBL] [Abstract][Full Text] [Related]
4. Effect of diclofenac alone or in combination with alpha-tocopherol on the oxidative activity of polymorphonuclear leukocytes in healthy and osteoarthritic individuals.
Al-Arfaj AS; Alballa SR; Mustafa AA; Al-Tuwaijri AS; Al-Dalaan AN; Al-Humayyd MS
Saudi Med J; 2004 Feb; 25(2):198-203. PubMed ID: 14968218
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients.
Vachier I; Chanez P; Le Doucen C; Damon M; Descomps B; Godard P
Eur Respir J; 1994 Sep; 7(9):1585-92. PubMed ID: 7995385
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
[TBL] [Abstract][Full Text] [Related]
7. Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.
Lipworth BJ; Dempsey OJ; Aziz I; Wilson AM
Am J Med; 2000 Aug; 109(2):114-21. PubMed ID: 10967152
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary data.
Centanni S; Santus P; Casanova F; Di Marco F; Brazzola G; Canonica GW
Drugs Exp Clin Res; 2000; 26(4):133-8. PubMed ID: 11109513
[TBL] [Abstract][Full Text] [Related]
9. The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.
Lazarus SC; Wong HH; Watts MJ; Boushey HA; Lavins BJ; Minkwitz MC
Am J Respir Crit Care Med; 1997 Dec; 156(6):1725-30. PubMed ID: 9412547
[TBL] [Abstract][Full Text] [Related]
10. Verapamil enhances the inhibitory effect of diclofenac on the chemiluminescence of human polymorphonuclear leukocytes and carrageenan-induced rat's paw oedema.
al-Tuwaijri AS; Mustafa AA
Int J Immunopharmacol; 1992 Jan; 14(1):83-91. PubMed ID: 1582737
[TBL] [Abstract][Full Text] [Related]
11. The effects of add-on zafirlukast treatment to budesonide on bronchial hyperresponsiveness and serum levels of eosinophilic cationic protein and total antioxidant capacity in asthmatic patients.
Cakmak G; Demir T; Gemicioglu B; Aydemir A; Serdaroglu E; Donma O
Tohoku J Exp Med; 2004 Dec; 204(4):249-56. PubMed ID: 15572850
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of zafirlukast in the treatment of patients with bronchial asthma.
Tsai JJ; Chan SC; Ho CK; Su YC; Feng TC
J Microbiol Immunol Infect; 2001 Mar; 34(1):63-70. PubMed ID: 11321130
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and tolerability of zafirlukast for the treatment of asthma in children.
Pearlman DS; Lampl KL; Dowling PJ; Miller CJ; Bonuccelli CM
Clin Ther; 2000 Jun; 22(6):732-47. PubMed ID: 10929920
[TBL] [Abstract][Full Text] [Related]
14. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials.
Barnes NC; Miller CJ
Thorax; 2000 Jun; 55(6):478-83. PubMed ID: 10817796
[TBL] [Abstract][Full Text] [Related]
15. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
Smith LJ; Hanby LA; Lavins BJ; Simonson SG
Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572
[TBL] [Abstract][Full Text] [Related]
16. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.
Fish JE; Kemp JP; Lockey RF; Glass M; Hanby LA; Bonuccelli CM
Clin Ther; 1997; 19(4):675-90. PubMed ID: 9377612
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma.
Kemp JP; Minkwitz MC; Bonuccelli CM; Warren MS
Chest; 1999 Feb; 115(2):336-42. PubMed ID: 10027429
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.
Tashkin DP; Nathan RA; Howland WC; Minkwitz MC; Simonson SG; Bonuccelli CM
J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):246-54. PubMed ID: 9949315
[TBL] [Abstract][Full Text] [Related]
19. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
Kelloway JS
Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
Suissa S; Dennis R; Ernst P; Sheehy O; Wood-Dauphinee S
Ann Intern Med; 1997 Feb; 126(3):177-83. PubMed ID: 9027267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
